These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36543076)

  • 1. Hemodynamic Gain Index and Exercise Capacity in Heart Failure With Preserved Ejection Fraction.
    Morales-Oyarvide V; Richards D; Hendren NS; Michelis K; Chaikijurajai T; MacNamara JP; Sarma S; Farr MA; Drazner MH; Tang WHW; Grodin JL
    Am J Cardiol; 2023 Mar; 190():17-24. PubMed ID: 36543076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study.
    Zakeri R; Borlaug BA; McNulty SE; Mohammed SF; Lewis GD; Semigran MJ; Deswal A; LeWinter M; Hernandez AF; Braunwald E; Redfield MM
    Circ Heart Fail; 2014 Jan; 7(1):123-30. PubMed ID: 24162898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resting ventricular-vascular function and exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study.
    Mohammed SF; Borlaug BA; McNulty S; Lewis GD; Lin G; Zakeri R; Semigran MJ; LeWinter M; Hernandez AF; Braunwald E; Redfield MM
    Circ Heart Fail; 2014 Jul; 7(4):580-9. PubMed ID: 24833648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left atrial function and maximal exercise capacity in heart failure with preserved and mid-range ejection fraction.
    Maffeis C; Morris DA; Belyavskiy E; Kropf M; Radhakrishnan AK; Zach V; Rozados da Conceicao C; Trippel TD; Pieske-Kraigher E; Rossi A; Pieske B; Edelmann F
    ESC Heart Fail; 2021 Feb; 8(1):116-128. PubMed ID: 33295106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart rate response and functional capacity in patients with chronic heart failure with preserved ejection fraction.
    Domínguez E; Palau P; Núñez E; Ramón JM; López L; Melero J; Bellver A; Santas E; Chorro FJ; Núñez J
    ESC Heart Fail; 2018 Aug; 5(4):579-585. PubMed ID: 29573575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diastolic stress test echocardiography in patients with suspected heart failure with preserved ejection fraction: a pilot study.
    Belyavskiy E; Morris DA; Url-Michitsch M; Verheyen N; Meinitzer A; Radhakrishnan AK; Kropf M; Frydas A; Ovchinnikov AG; Schmidt A; Tadic M; Genger M; Lindhorst R; Bobenko A; Tschöpe C; Edelmann F; Pieske-Kraigher E; Pieske B
    ESC Heart Fail; 2019 Feb; 6(1):146-153. PubMed ID: 30451399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying a low-flow phenotype in heart failure with preserved ejection fraction: a secondary analysis of the RELAX trial.
    Patel KV; Mauricio R; Grodin JL; Ayers C; Fonarow GC; Berry JD; Pandey A
    ESC Heart Fail; 2019 Aug; 6(4):613-620. PubMed ID: 30993916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction.
    Kasner M; Aleksandrov AS; Westermann D; Lassner D; Gross M; von Haehling S; Anker SD; Schultheiss HP; Tschöpe C
    Int J Cardiol; 2013 Oct; 168(5):4652-7. PubMed ID: 23968714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume.
    Lam CS; Rienstra M; Tay WT; Liu LC; Hummel YM; van der Meer P; de Boer RA; Van Gelder IC; van Veldhuisen DJ; Voors AA; Hoendermis ES
    JACC Heart Fail; 2017 Feb; 5(2):92-98. PubMed ID: 28017355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contributions of Nondiastolic Factors to Exercise Intolerance in Heart Failure With Preserved Ejection Fraction.
    Kosmala W; Rojek A; Przewlocka-Kosmala M; Mysiak A; Karolko B; Marwick TH
    J Am Coll Cardiol; 2016 Feb; 67(6):659-670. PubMed ID: 26868691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular phenotype in HFpEF patients with or without diabetes: a RELAX trial ancillary study.
    Lindman BR; Dávila-Román VG; Mann DL; McNulty S; Semigran MJ; Lewis GD; de las Fuentes L; Joseph SM; Vader J; Hernandez AF; Redfield MM
    J Am Coll Cardiol; 2014 Aug; 64(6):541-9. PubMed ID: 25104521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 in Patients With Heart Failure and Preserved Ejection Fraction.
    Alogna A; Koepp KE; Sabbah M; Espindola Netto JM; Jensen MD; Kirkland JL; Lam CSP; Obokata M; Petrie MC; Ridker PM; Sorimachi H; Tchkonia T; Voors A; Redfield MM; Borlaug BA
    JACC Heart Fail; 2023 Nov; 11(11):1549-1561. PubMed ID: 37565977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neurohormonal basis of pulmonary hypertension in heart failure with preserved ejection fraction.
    Obokata M; Kane GC; Reddy YNV; Melenovsky V; Olson TP; Jarolim P; Borlaug BA
    Eur Heart J; 2019 Dec; 40(45):3707-3717. PubMed ID: 31513270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of complication of type 2 diabetes mellitus with hemodynamics and exercise capacity in patients with heart failure with preserved ejection fraction: a case-control study in individuals aged 65-80 years.
    Sugita Y; Ito K; Yoshioka Y; Sakai S
    Cardiovasc Diabetol; 2023 Apr; 22(1):97. PubMed ID: 37118820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of Effort Intolerance in Patients With Heart Failure: Combined Echocardiography and Cardiopulmonary Stress Protocol.
    Shimiaie J; Sherez J; Aviram G; Megidish R; Viskin S; Halkin A; Ingbir M; Nesher N; Biner S; Keren G; Topilsky Y
    JACC Heart Fail; 2015 Oct; 3(10):803-14. PubMed ID: 26449998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combined exercise stress echocardiography and cardiopulmonary exercise test for identification of masked heart failure with preserved ejection fraction in patients with hypertension.
    Nedeljkovic I; Banovic M; Stepanovic J; Giga V; Djordjevic-Dikic A; Trifunovic D; Nedeljkovic M; Petrovic M; Dobric M; Dikic N; Zlatar M; Beleslin B
    Eur J Prev Cardiol; 2016 Jan; 23(1):71-7. PubMed ID: 26358991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the Obese Phenotype of Heart Failure With Preserved Ejection Fraction: A RELAX Trial Ancillary Study.
    Reddy YNV; Lewis GD; Shah SJ; Obokata M; Abou-Ezzedine OF; Fudim M; Sun JL; Chakraborty H; McNulty S; LeWinter MM; Mann DL; Stevenson LW; Redfield MM; Borlaug BA
    Mayo Clin Proc; 2019 Jul; 94(7):1199-1209. PubMed ID: 31272568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the transition to and progression of heart failure with preserved ejection fraction: a weighted risk score using bio-humoural, cardiopulmonary, and echocardiographic stress testing.
    Pugliese NR; De Biase N; Gargani L; Mazzola M; Conte L; Fabiani I; Natali A; Dini FL; Frumento P; Rosada J; Taddei S; Borlaug BA; Masi S
    Eur J Prev Cardiol; 2021 Dec; 28(15):1650-1661. PubMed ID: 33624088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: insights from the RELAX trial.
    DeVore AD; McNulty S; Alenezi F; Ersboll M; Vader JM; Oh JK; Lin G; Redfield MM; Lewis G; Semigran MJ; Anstrom KJ; Hernandez AF; Velazquez EJ
    Eur J Heart Fail; 2017 Jul; 19(7):893-900. PubMed ID: 28194841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial Injury and Cardiac Reserve in Patients With Heart Failure and Preserved Ejection Fraction.
    Obokata M; Reddy YNV; Melenovsky V; Kane GC; Olson TP; Jarolim P; Borlaug BA
    J Am Coll Cardiol; 2018 Jul; 72(1):29-40. PubMed ID: 29957229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.